Howard R. Soule

Executive Vice President Chief Science Officer at Prostate Cancer Foundation

Howard R. Soule

Howard R. Soule

Executive Vice President Chief Science Officer at Prostate Cancer Foundation

Overview
RelSci Relationships

874

Number of Boards

5

Contact Data
Trying to get in touch with Howard R. Soule? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
View Relationship Details
RelSci Relationships are individuals Howard R. Soule likely has professional access to. A relationship does not necessarily indicate a personal connection.
Michael Milken

Founder at Milken Family Foundation

Relationship likelihood: Strong

Stuart Holden

Board Member & Medical Director at Prostate Cancer Foundation

Relationship likelihood: Strong

Philip Kantoff

Chairman, Global Treatment Sciences Network at Prostate Cancer Foundation

Relationship likelihood: Strong

Anthony Coelho

Founding Partner at Vectis Strategies

Relationship likelihood: Strong

Jonathan W. Simons

President & Chief Executive Officer at Prostate Cancer Foundation

Relationship likelihood: Strong

Ralph Finerman

Chief Financial Officer, Treasurer & Secretary at Prostate Cancer Foundation

Relationship likelihood: Strong

Brooke E. Gordon

Vice Chairman at Epilepsy Foundation of America

Relationship likelihood: Strong

Donald J. Hayden, Jr.

Chief Executive Officer at Windmil Therapeutics, Inc.

Relationship likelihood: Strong

Robert W. Smith

Treasurer & Director at Epilepsy Foundation of America

Relationship likelihood: Strong

J. May Liang

Director at Epilepsy Foundation of America

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
In The News
Business Wire
March 29, 2021
Fortis Therapeutics Closes $40 Million Series A Financing to Advance Novel Anti-CD46 Therapeutic to Treat Late-Stage Prostate Cancer and Multiple Myeloma
PR Newswire
December 16, 2020
The Prostate Cancer Foundation And Cancer Research Innovation In Science Announce 2020 Young Investigator Award Winners
PR Newswire
November 18, 2020
The Prostate Cancer Foundation And Movember Announce 2020 Challenge Award Winners
The Daily Telegraph (London)
June 5, 2020
Baldness linked to a greater risk of severe coronavirus symptoms
Business Wire
May 15, 2020
Rubraca® (Rucaparib) Approved in the U.S. as Monotherapy Treatment for Patients with BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer (mCRPC) Who Have Been Treated with Androgen Receptor-Directed Therapy and a Taxane-Based Chemotherapy; Rub
Trending People
Andrea Agnelli
'OK, bye': Premier League players react to European Super League's collapse - The Independent UK
Boris Johnson
Sadiq Khan slaps down Boris Johnson call for Ronald Reagan statue outside parlia... - City AM
Merrick B. Garland
Statement of Attorney General Merrick B. Garland on the Verdict in the Chauvin T... - Legal Monitor Worldwide
Thomas H. Gardner
American Water Works Earnings: What to Watch on May 3 - Nasdaq
Nancy Pelosi
With Markey on the job, no need to fear court-packing - Boston Herald
Trending People
Andrea Agnelli
'OK, bye': Premier League players react to European Super League's collapse - The Independent UK
Boris Johnson
Sadiq Khan slaps down Boris Johnson call for Ronald Reagan statue outside parlia... - City AM
Merrick B. Garland
Statement of Attorney General Merrick B. Garland on the Verdict in the Chauvin T... - Legal Monitor Worldwide
Thomas H. Gardner
American Water Works Earnings: What to Watch on May 3 - Nasdaq
Nancy Pelosi
With Markey on the job, no need to fear court-packing - Boston Herald
Paths to Howard R. Soule
Potential Connections via
Relationship Science
You
Howard R. Soule
Executive Vice President Chief Science Officer at Prostate Cancer Foundation
Education
Ph.D. in Virology & Epidemiology
Baylor College of Medicine

Baylor College of Medicine is a health sciences university that creates knowledge and applies science and discoveries to further education, healthcare and community service locally and globally.

Career History
Executive Vice President Chief Science Officer
Current
Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF), formerly known as CaP CURE, is the world’s largest philanthropic source of support for prostate cancer research. PCF was founded in 1993 in order to discover better treatments and a cure for prostate cancer. As of 2012, PCF has raised more than $500 million for research and funded more than 1,600 research projects at nearly 200 institutions in 17 countries. In the past 2 years, 5 new drugs that extend the lives of men with metastatic prostate cancer have been approved by the FDA. PCF initiated and supported academic treatment science that fast-forwarded every one of these approvals.

Senior Fellow
Current
Milken Institute

A nonprofit, nonpartisan think tank, the Milken Institute believes in the power of capital markets to solve urgent social and economic challenges and improve lives. To build a foundation of rigorous, independent research, it has assembled a respected team of economists, industry experts and scholars to analyze the issues and choices facing policymakers. It convenes a network of influential decision-makers from the private and public sectors to help transform ideas into action. The Milken Institute partners with global leaders in finance, business, government, science and philanthropy -- people with the vision and resources to make a significant impact.

Advisor
Prior - 2008
ProQuest Management LLC

ProQuest Management invests in healthcare companies located in the US. The sectors in which they invest include biotech and pharmaceutical companies. The firm provides financing for seed to late-stage capital requirements and the firm invests in both public & private companies.

Boards & Committees
Member, Science Advisory Board
Current
Exosome Diagnostics, Inc.

Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.
Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 +
2012
Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF), formerly known as CaP CURE, is the world’s largest philanthropic source of support for prostate cancer research. PCF was founded in 1993 in order to discover better treatments and a cure for prostate cancer. As of 2012, PCF has raised more than $500 million for research and funded more than 1,600 research projects at nearly 200 institutions in 17 countries. In the past 2 years, 5 new drugs that extend the lives of men with metastatic prostate cancer have been approved by the FDA. PCF initiated and supported academic treatment science that fast-forwarded every one of these approvals.

Events
Speaker
Los Angeles, CA, United States
2013 Milken Institute Global Conference

Through a unique international agenda and some of the smartest speakers on the planet, the Milken Institute Global Conference tackles the world’s most difficult challenges in an array of fields - from finance and philanthropy, to the environment and education, to government and health.

Speaker
Los Angeles, CA, United States
2012 Milken Institute Global Conference

Through a unique international agenda and some of the smartest speakers on the planet, the Milken Institute Global Conference tackles the world’s most difficult challenges in an array of fields - from finance and philanthropy, to the environment and education, to government and health.

Speaker
Los Angeles, CA, United States
2011 Milken Institute Global Conference

The 2011 Milken Institute Global Conference brings together some of the most extraordinary people in the world - from entrepreneurs and executives to philanthropists, scientists and Nobel laureates. Together they explore solutions to today's most pressing social, political and economic challenges.

Other Affiliations

Howard R. Soule is affiliated with Prostate Cancer Foundation, Milken Institute, ProQuest Management LLC, Corvas International, Inc., Knowledge Universe Health and Wellness Group, The Scripps Research Institute - California, Exosome Diagnostics, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Howard R. Soule. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Howard R. Soule's profile does not indicate a business or promotional relationship of any kind between RelSci and Howard R. Soule.